Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

Guy Jérusalem, Subrina Farah, Anne-Catherine Courtois, Jacquie Chirgwin, Stefan Aebi, Per Karlsson, Patrick Neven, Erika Hitre, Marie-Pascale Graas, Edda Simoncini, Ehtesham Abdi, Claus Kamby, Alastair M. Thompson, Sibylle Loibl, Joaquín Gavilá, Katsumasa Kuroi, Christian Marth, Bettina Müller, Séamus O’Reilly, Andrea Gombos, Thomas Ruhstaller, Harold J. Burstein, Manuela Rabaglio, Barbara Ruepp, Karin Ribi, Giuseppe Viale, Richard D. Gelber, Alan S. Coates, Sherene Loi, Aron Goldhirsch, Meredith M. Regan, Marco Colleoni